YmAbs Therapeutics (YMAB)
(Delayed Data from NSDQ)
$13.73 USD
-0.27 (-1.93%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $13.71 -0.02 (-0.15%) 5:42 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.10 |
EPS Last Quarter | -0.21 |
Last EPS Surprise | -61.54% |
ABR | 1.59 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.57 |
Next Year | -0.38 |
EPS (TTM) | -0.56 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 24.16M | 25.94M | 94.03M | 111.59M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 25.30M | 27.53M | 95.56M | 118.43M |
Low Estimate | 22.50M | 23.29M | 92.03M | 102.05M |
Year ago Sales | 20.45M | 23.36M | 84.82M | 94.03M |
Year over Year Growth Est. | 18.15% | 11.05% | 10.86% | 18.67% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.10 | -0.08 | -0.57 | -0.38 |
# of Estimates | 4 | 4 | 6 | 5 |
Most Recent Consensus | -0.09 | -0.06 | -0.67 | -0.25 |
High Estimate | -0.08 | -0.03 | -0.47 | -0.24 |
Low Estimate | -0.15 | -0.15 | -0.67 | -0.62 |
Year ago EPS | -0.18 | -0.02 | -0.49 | -0.57 |
Year over Year Growth Est. | 44.44% | -300.00% | -16.33% | 32.92% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 3 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 1 | 3 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.10 | -0.08 | -0.57 | -0.38 |
7 Days Ago | -0.10 | -0.08 | -0.57 | -0.38 |
30 Days Ago | -0.10 | -0.08 | -0.57 | -0.38 |
60 Days Ago | -0.13 | -0.14 | -0.52 | -0.47 |
90 Days Ago | -0.10 | -0.11 | -0.45 | -0.35 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.10 | -0.08 | -0.57 | -0.38 |
Zacks Consensus Estimate | -0.10 | -0.08 | -0.57 | -0.38 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.21 | -0.15 | -0.02 | -0.18 | NA |
Estimate | -0.13 | -0.12 | -0.19 | -0.16 | NA |
Difference | -0.08 | -0.03 | 0.17 | -0.02 | 0.01 |
Surprise | -61.54% | -25.00% | 89.47% | -12.50% | -2.39% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more